The Importance of Following Your Doctor's Dosage Instructions

🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No. BXNZ2488), falsely claiming to be manufactured by Bayer Pharma AG, Germany.

Access through your organization

According to a statement issued on Wednesday, the counterfeit medicines identified are Efaston tablets (Dydrogesterone 10mg) and Paracare suspension 60ml (Paracetamol 120mg/5ml). Laboratory analysis revealed that both products lack active pharmaceutical ingredients, rendering them ineffective and unsafe for public use. DRAP warned that such falsified drugs pose a serious threat to public health, potentially leading to treatment failure, worsening of illness, or life-threatening complications particularly for patients relying on them for essential therapies. The authority has advised citizens to stop using these products immediately and to consult healthcare professionals if they experience any adverse effects. Consumers have also been urged to verify batch numbers before purchasing medicines and to report suspicious products to local health authorities.

Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy

In addition, pharmacies, hospitals, and healthcare providers have been instructed to monitor their supply chains closely and report any quality or safety concerns related to the two medicines to DRAP without delay. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in 🚨 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐔𝐩𝐝𝐚𝐭𝐞 - 𝐈𝐜𝐞𝐥𝐚𝐧𝐝: 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐨𝐧 𝐒𝐚𝐟𝐞𝐭𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 (𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝟎𝟔 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟓) 📅 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. 𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 ✓ Clear definition of electronic distribution and what constitutes electronic dissemination of safety information (Section: Dissemination of Safety Information) ✓ Clarification that safety information related to pharmaceutical forms not marketed in Iceland will not be assessed by the Icelandic Medicines Agency (Section: 1.6 Review by the Icelandic Medicines Agency and Dissemination of Safety Information) ✓ Aimed at strengthening regulatory transparency and consistency in safety information handling 𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬 This update enhances efficiency and clarity in the regulatory process, ensuring streamlined communication and compliance for Marketing Authorization Holders (MAHs) operating within Iceland. It reinforces a transparent and harmonized approach to safety information management.

The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction

🌍 At Viginovix, we continuously monitor global pharmacovigilance and regulatory updates to help our partners uphold compliance, safety excellence, and readiness across all regions. 📩 info@viginovix.com & awanishpandey@viginovix.com 🌐 👉 What are your thoughts on how local regulatory clarifications contribute to global pharmacovigilance harmonization? #RegulatoryUpdate #Pharmacovigilance #DrugSafety #RegulatoryAffairs #Viginovix To view or add a comment, sign in 🚨 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐔𝐩𝐝𝐚𝐭𝐞 - 𝐈𝐜𝐞𝐥𝐚𝐧𝐝: 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐨𝐧 𝐒𝐚𝐟𝐞𝐭𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 (𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝟎𝟔 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟓) 📅 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. To view or add a comment, sign in Here's a comprehensive overview of the significance of various regulatory bodies, quality standards, and research methodologies in the pharmaceutical industry: Regulatory Bodies 1- USFDA (United States Food and Drug Administration) Ensures the safety and efficacy of drugs, biologics, and medical devices in the US. USFDA approval is considered a gold standard for pharmaceutical products globally. Testing by the Central Drugs Laboratory confirmed that this batch is falsified and unregistered. Its safety, quality, and efficacy have not been evaluated or approved. Use of such medicines can result in treatment failure, adverse reactions, or serious health risks.

Product	Dosage	Quantity + Bonus	Price
Levitra Professional	20mg	10 Pills	62.37€ 59.40€	Buy
Levitra Generic	20mg	120 + 10 Pills	224.15€ 213.48€	Buy
Levitra Generic	60mg	270 + 10 Pills	714.53€ 680.50€	Buy
Levitra Original	20mg	34 + 2 Pills	188.51€ 179.53€	Buy
Levitra Original	20mg	64 + 4 Pills	298.45€ 284.24€	Buy
Levitra Generic	10mg	90 + 8 Pills	150.58€ 143.41€	Buy
Levitra Generic	10mg	180 + 10 Pills	246.74€ 234.99€	Buy
Levitra Soft Tabs	20mg	270 + 10 Pills	521.78€ 496.93€	Buy
Levitra Professional	20mg	60 + 2 Pills	223.11€ 212.49€	Buy
Levitra Generic	10mg	30 + 4 Pills	62.39€ 59.42€	Buy
Levitra Generic	60mg	120 + 8 Pills	372.33€ 354.60€	Buy
Levitra Professional	20mg	90 + 2 Pills	304.49€ 289.99€	Buy
Levitra Soft Tabs	20mg	10 Pills	52.27€ 49.78€	Buy
Levitra Generic	20mg	20 Pills	52.63€ 50.12€	Buy
Levitra Original	20mg	22 + 2 Pills	138.55€ 131.95€	Buy
Levitra Generic	60mg	180 + 10 Pills	501.43€ 477.55€	Buy
Levitra Soft Tabs	20mg	360 + 20 Pills	682.21€ 649.72€	Buy

Regulatory Action: DRAP has instructed its field and provincial authorities to seize this product. Pharmacies, distributors, and healthcare institutions are advised to check their inventories immediately and report any presence of this batch to the authorities. For Healthcare Professionals: Stay vigilant for falsified or unregistered medicines. Report any suspected cases or adverse reactions to DRAP’s pharmacovigilance system. Always purchase medicines from licensed pharmacies and verify their registration details. Seek medical attention if you experience any unusual effects.

Levitra side effects

Ensuring medicine safety is a shared responsibility. Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No.

Levitra Versus Other ED Medications

2- UK MHRA (Medicines and Healthcare products Regulatory Agency) Regulates medicines and medical devices in the UK, ensuring their safety, quality, and efficacy. 3- FSSAI (Food Safety and Standards Authority of India) Regulates food safety and standards in India, ensuring the quality and safety of food products. Quality Standards 1- GMP (Good Manufacturing Practice) A set of guidelines ensuring pharmaceutical products are manufactured, tested, and packaged in a controlled environment to meet quality standards. 2- ISO 9000 A series of quality management standards that help organizations ensure their products or services meet customer and regulatory requirements. Research Methodologies 1- Double-blind placebo-controlled studies A research design where participants are randomly assigned to treatment or placebo groups, and both participants and researchers are blinded to the treatment assignments.

J. Urol.

This design helps minimize bias and ensures the reliability of results. 2- Case trials studies Also known as clinical trials, these studies evaluate the safety and efficacy of new treatments or interventions in humans. 3- Black box symbol A warning label required by regulatory agencies, such as the USFDA, to highlight serious or life-threatening risks associated with a particular medication. Intellectual Property and Standards 1- IP (Intellectual Property) Refers to patents, trademarks, copyrights, and trade secrets that protect innovations and creations in the pharmaceutical industry.

ScriptSave WellRx

Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). 𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗣𝗮𝘁𝗵𝘄𝗮𝘆𝘀 🔸There are two main types of listed medicines: 🔸AUST L medicines: These are low-risk and do not undergo pre-market efficacy review. 🔸AUST L(A) medicines: Also low-risk, but they require TGA assessment of efficacy evidence and may carry a “TGA assessed” claim. 𝗦𝗽𝗼𝗻𝘀𝗼𝗿 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 Sponsors must certify that their medicine: 🔸Is eligible for listing under the Act. 🔸Contains only permissible ingredients and meets all ingredient-related requirements.

Parameter	Value	Description
Absorption	Rapid, within 30-60 mins	Peak plasma concentrations
Bioavailability	Approximately 15-40%	Depends on food and individual factors
Half-life	About 4-5 hours	Duration in plasma
Metabolism	Liver via CYP3A4	Mainly by liver enzymes

🔸Complies with advertising, manufacturing, and GMP standards. 🔸Has written agreements with all nominated manufacturers. 🔸Includes only approved indications and claims, with supporting evidence. 🔸Does not contain prohibited substances or imports. 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 Sponsors use the TGA Business Services portal to: 🔸Enter product details. 🔸Receive an AUST L or AUST L(A) number and certificate. 𝗣𝗼𝘀𝘁-𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 Once listed, sponsors must: 🔸Maintain pharmacovigilance records and report adverse events. 🔸Comply with any ingredient-specific conditions (e.g., standards for Ginkgo biloba). 🔸Notify the TGA mail order levitra online of overseas recalls or safety issues. 𝗠𝗮𝗸𝗶𝗻𝗴 𝗖𝗵𝗮𝗻𝗴𝗲𝘀 Sponsors may request changes to their ARTG entry to: 🔸Correct errors.

How should I use Levitra?

🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No. BXNZ2488), falsely claiming to be manufactured by Bayer Pharma AG, Germany. Testing by the Central Drugs Laboratory confirmed that this batch is falsified and unregistered. Its safety, quality, and efficacy have not been evaluated or approved. Use of such medicines can result in treatment failure, adverse reactions, or serious health risks.

Patient resources

Regulatory Action: DRAP has instructed its field and provincial authorities to seize this product. Pharmacies, distributors, and healthcare institutions are advised to check their inventories immediately and report any presence of this batch to the authorities. For Healthcare Professionals: Stay vigilant for falsified or unregistered medicines. Report any suspected cases or adverse reactions to DRAP’s pharmacovigilance system. Always purchase medicines from licensed pharmacies and verify their registration details.

General Dose Information

Seek medical attention if you experience any unusual effects. Ensuring medicine safety is a shared responsibility. Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 🚨 RegAlert 067-025 Public Safety Notice The Drug Regulatory Authority of Pakistan (DRAP) has issued a Rapid Alert against an unregistered and substandard product being sold under the name Levitra 20 mg Tablet (Batch No. Read the full notice here: 👉 Rapid Alert : #RegAlert #DRAP #Pharmacovigilance #DrugSafety #HealthcarePakistan #PublicHealth #PharmacyProfession #MedicineAlert #PatientSafety #QualityMatters To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). 𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗣𝗮𝘁𝗵𝘄𝗮𝘆𝘀 🔸There are two main types of listed medicines: 🔸AUST L medicines: These are low-risk and do not undergo pre-market efficacy review. 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country. According to a statement issued on Wednesday, the counterfeit medicines identified are Efaston tablets (Dydrogesterone 10mg) and Paracare suspension 60ml (Paracetamol 120mg/5ml). Laboratory analysis revealed that both products lack active pharmaceutical ingredients, rendering them ineffective and unsafe for public use. DRAP warned that such falsified drugs pose a serious threat to public health, potentially leading to treatment failure, worsening of illness, or life-threatening complications particularly for patients relying on them for essential therapies.

• Levitra 20 mg Bayer has a proven track record for efficacy.
• It’s important to inform your doctor of any side effects experienced.
• Lifestyle changes can improve ED alongside medication.
• Risk factors for ED include diabetes, obesity, and smoking.
• Consultation with a healthcare provider ensures safe use.
• Levitra 20 mg Bayer is suitable for many but not all men.
• Don’t share your medication with others to avoid misuse.
• The tablet’s effects can be unpredictable if taken with certain foods.
• Follow-up testing might be needed for underlying medical issues.
• The medication is part of a comprehensive sexual health plan.
• Use discretion and discretion when discussing medication use.

The authority has advised citizens to stop using these products immediately and to consult healthcare professionals if they experience any adverse effects.

• Levitra 20 mg Bayer is designed for adult men with ED.
• It should be used with caution in patients with liver or kidney issues.
• The medication may cause visual disturbances in some users.
• Levitra 20 mg Bayer does not protect against sexually transmitted infections.
• Measuring your response can help determine proper dosage.
• Avoid taking Levitra if you have any known allergies to it.
• Some users report improved confidence after taking Levitra.
• The drug can sometimes cause a mild decrease in blood pressure.
• You should not crush or chew the tablets; swallow whole.
• Use medication only as prescribed by a healthcare professional.
• Levitra 20 mg Bayer is part of a broader class of ED treatments.

Consumers have also been urged to verify batch numbers before purchasing medicines and to report suspicious products to local health authorities.

What happens if I overdose?

🔸AUST L(A) medicines: Also low-risk, but they require TGA assessment of efficacy evidence and may carry a “TGA assessed” claim. 𝗦𝗽𝗼𝗻𝘀𝗼𝗿 𝗖𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 Sponsors must certify that their medicine: 🔸Is eligible for listing under the Act. 🔸Contains only permissible ingredients and meets all ingredient-related requirements. 🔸Complies with advertising, manufacturing, and GMP standards. 🔸Has written agreements with all nominated manufacturers.

Sustained efficacy and tolerability of vardenafil (Levitra®), a highly potent, selective phosphodiesterase-5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

🔸Includes only approved indications and claims, with supporting evidence. 🔸Does not contain prohibited substances or imports. 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 Sponsors use the TGA Business Services portal to: 🔸Enter product details. 🔸Receive an AUST L or AUST L(A) number and certificate. 𝗣𝗼𝘀𝘁-𝗟𝗶𝘀𝘁𝗶𝗻𝗴 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 Once listed, sponsors must: 🔸Maintain pharmacovigilance records and report adverse events.

Related treatment guides

🔸Comply with any ingredient-specific conditions (e.g., standards for Ginkgo biloba). 🔸Notify the TGA mail order levitra online of overseas recalls or safety issues. 𝗠𝗮𝗸𝗶𝗻𝗴 𝗖𝗵𝗮𝗻𝗴𝗲𝘀 Sponsors may request changes to their ARTG entry to: 🔸Correct errors. 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in 📌𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗹𝗲𝗴𝗶𝘀𝗹𝗮𝘁𝗶𝘃𝗲 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝗹𝗶𝘀𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 This Therapeutic Goods Administration guidance helps sponsors understand how to legally list low-risk medicines (AUST L and AUST L(A)) on the Australian Register of Therapeutic Goods (ARTG). 🔸Some changes may result in a new product classification, requiring a separate ARTG entry unless grouped under the “Groups Order.” 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 🙏 for 𝘆𝗼𝘂𝗿 time and please 𝗟𝗶𝗸𝗲 👍, 𝗦𝗵𝗮𝗿𝗲, and/or 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 #medicaldevices #invitrodiagnostics #combinationproducts #qualityassurance #regulatoryaffairs #pharmaceuticals To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country. In addition, pharmacies, hospitals, and healthcare providers have been instructed to monitor their supply chains closely and report any quality or safety concerns related to the two medicines to DRAP without delay. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has declared two widely available medicines as spurious, directing provincial drug inspectors to immediately seize the affected products from markets across the country. #DRAP #HealthAlert #FakeMedicines #PublicWarning #Pakistan #PharmaSafety #DrugRegulation #Efaston #Paracare #CounterfeitDrugs To view or add a comment, sign in 🚨 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐔𝐩𝐝𝐚𝐭𝐞 - 𝐈𝐜𝐞𝐥𝐚𝐧𝐝: 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐨𝐧 𝐒𝐚𝐟𝐞𝐭𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 (𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝟎𝟔 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟓) 📅 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market.

Trial purpose

𝐊𝐞𝐲 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 ✓ Clear definition of electronic distribution and what constitutes electronic dissemination of safety information (Section: Dissemination of Safety Information) ✓ Clarification that safety information related to pharmaceutical forms not marketed in Iceland will not be assessed by the Icelandic Medicines Agency (Section: 1.6 Review by the Icelandic Medicines Agency and Dissemination of Safety Information) ✓ Aimed at strengthening regulatory transparency and consistency in safety information handling 𝐖𝐡𝐲 𝐈𝐭 𝐌𝐚𝐭𝐭𝐞𝐫𝐬 This update enhances efficiency and clarity in the regulatory process, ensuring streamlined communication and compliance for Marketing Authorization Holders (MAHs) operating within Iceland. It reinforces a transparent and harmonized approach to safety information management. 🌍 At Viginovix, we continuously monitor global pharmacovigilance and regulatory updates to help our partners uphold compliance, safety excellence, and readiness across all regions. 📩 info@viginovix.com & awanishpandey@viginovix.com 🌐 👉 What are your thoughts on how local regulatory clarifications contribute to global pharmacovigilance harmonization? #RegulatoryUpdate #Pharmacovigilance #DrugSafety #RegulatoryAffairs #Viginovix To view or add a comment, sign in 🚨 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐔𝐩𝐝𝐚𝐭𝐞 - 𝐈𝐜𝐞𝐥𝐚𝐧𝐝: 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞 𝐨𝐧 𝐒𝐚𝐟𝐞𝐭𝐲 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 (𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝟎𝟔 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟎𝟐𝟓) 📅 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝: 06 October 2025 The Icelandic Medicines Agency (Lyfjastofnun) has published an updated Guidance on Safety Information on its official website, providing greater clarity on the dissemination and review of safety information in the Icelandic market. To view or add a comment, sign in Here's a comprehensive overview of the significance of various regulatory bodies, quality standards, and research methodologies in the pharmaceutical industry: Regulatory Bodies 1- USFDA (United States Food and Drug Administration) Ensures the safety and efficacy of drugs, biologics, and medical devices in the US. USFDA approval is considered a gold standard for pharmaceutical products globally. 2- UK MHRA (Medicines and Healthcare products Regulatory Agency) Regulates medicines and medical devices in the UK, ensuring their safety, quality, and efficacy. 3- FSSAI (Food Safety and Standards Authority of India) Regulates food safety and standards in India, ensuring the quality and safety of food products. Quality Standards 1- GMP (Good Manufacturing Practice) A set of guidelines ensuring pharmaceutical products are manufactured, tested, and packaged in a controlled environment to meet quality standards. 2- ISO 9000 A series of quality management standards that help organizations ensure their products or services meet customer and regulatory requirements. Research Methodologies 1- Double-blind placebo-controlled studies A research design where participants are randomly assigned to treatment or placebo groups, and both participants and researchers are blinded to the treatment assignments.

• Levitra 20 mg Bayer is supplied in blister packs for convenience.
• It is essential to adhere to prescribed timing and dosage.
• OTC availability varies by country; prescription is generally required.
• Patients should report any unusual eye or vision changes promptly.
• Levitra’s effects can be influenced by other health conditions.
• Men should avoid unnecessary driving or dangerous activities after use.
• The medication is part of a balanced approach to sexual health.
• Levitra may require dose adjustments based on individual response.
• Avoid using other ED medications simultaneously without medical advice.
• Nutritional supplements claiming to enhance ED are not regulated.
• Proper storage and handling ensure medication effectiveness.

This design helps minimize bias and ensures the reliability of results. 2- Case trials studies Also known as clinical trials, these studies evaluate the safety and efficacy of new treatments or interventions in humans. 3- Black box symbol A warning label required by regulatory agencies, such as the USFDA, to highlight serious or life-threatening risks associated with a particular medication. Intellectual Property and Standards 1- IP (Intellectual Property) Refers to patents, trademarks, copyrights, and trade secrets that protect innovations and creations in the pharmaceutical industry.